ONT01
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ONT01, covering 2025-11-20 to 2026-03-30. Get the full timeline:
Most recent: Clinical Trial Update: ONT01 and Gemcitabine/Nab-paclitaxel as Second Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma [Phase 1, Phase 2]